InvestorsHub Logo
Followers 0
Posts 43
Boards Moderated 0
Alias Born 07/23/2016

Re: None

Wednesday, 01/17/2018 12:34:29 PM

Wednesday, January 17, 2018 12:34:29 PM

Post# of 17405
Don't get me wrong. I am long AUPH. I am far from an expert in this sector but logically speaking the only way BP would buy this is if its offered at a discount (to justify the risk of p3 failure). Why would Glickman sell this at a discount if he believes in a big success of Voclo? Surely it's better to wait for p3 results and then sell as they are fully funded until the trial is over.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News